This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
REVIEW UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
CORE-001 Study
ADSTILADRIN
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
Masofaniten (EPI-7386)
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
BCAN TT 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Beyond the Abstracts
Urologic Oncology
Prostate Cancer
Beyond the Abstracts
Optimizing Detection of Clinically Significant Prostate Cancer Through Nomograms Incorporating MRI, Clinical Features, and Advanced Serum Biomarkers in Biopsy Naïve Men - Beyond the Abstract
July 24, 2023
Vector Prostate Biopsy: A Novel Magnetic Resonance Imaging/Ultrasound Image Fusion Transperineal Biopsy Technique Using Electromagnetic Needle Tracking Under Local Anaesthesia - Beyond the Abstract
July 20, 2023
Intra-Practice Urologist-Level Variation in Targeted Fusion Biopsy Outcomes - Beyond the Abstract
July 10, 2023
Olaparib Tolerability and Common Adverse-Event Management in Patients with Metastatic Castration-Resistant Prostate Cancer: Further Analyses from the PROfound Study - Beyond the Abstract
July 6, 2023
Head-to-Head Comparison of the Diagnostic Accuracy of Prostate-Specific Membrane Antigen Positron Emission Tomography and Conventional Imaging Modalities for Initial Staging of Intermediate to High Risk Prostate Cancer - Beyond the Abstract
June 29, 2023
Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2) - Beyond the Abstract
June 29, 2023
Symptom Experiences of Older Adults During Treatment for Metastatic Prostate Cancer: A Qualitative Investigation - Beyond the Abstract
June 26, 2023
Impact of Prostate MRI Central Review over the Diagnostic Performance of MRI-Targeted Biopsy: Should We Routinely Ask for an Expert Second Opinion? - Beyond the Abstract
June 20, 2023
The Influence of Lifestyle Changes (Diet, Exercise and Stress Reduction) on Prostate Cancer Tumour Biology and Patient Outcomes: A Systematic Review - Beyond the Abstract
June 14, 2023
Simultaneous Hernia Repair Following Robotic-assisted Radical Prostatectomy is Safe With Low Rates of Mesh-related Complications - Beyond the Abstract
June 2, 2023
Contemporary Patterns of Local Ablative Therapies for Prostate Cancer at United States Cancer Centers: Results from a National Registry - Beyond the Abstract
May 31, 2023
The Efficacy of Enzalutamide plus Androgen Deprivation Therapy in Oligometastatic Hormone-sensitive Prostate Cancer: A Post Hoc Analysis of ARCHES - Beyond the Abstract
May 30, 2023
Feasibility and Acceptability of Remote Symptom Monitoring (RSM) in Older Adults During Treatment for Metastatic Prostate Cancer - Beyond the Abstract
May 30, 2023
Androgen Deprivation Therapy Plus Chemotherapy ± Androgen Receptor-Targeting Agents for Metastatic Hormone-sensitive Prostate Cancer - Beyond the Abstract
May 23, 2023
Prostate Cancer Screening-Stepping Forward with MRI - Beyond the Abstract
May 17, 2023
A Detailed Evaluation of the Effect of PSA-Based Screening on Morbidity and Mortality of Prostate Cancer: 21-year Follow-up Results of the Rotterdam Section of the European Randomized Study of Screening for Prostate Cancer - Beyond the Abstract
May 15, 2023
Prostate-Specific Antigen Response after Abiraterone Treatment in mCRPC: PSA as a Predictor of Overall Survival - Beyond the Abstract
May 15, 2023
Treatment of Localized Prostate Cancer in Elderly Patients: the Role of Partial Cryoablation - Beyond the Abstract
May 12, 2023
Transgender Women with Prostate Cancer Are Under-Represented in National Cancer Registries - Beyond the Abstract
May 11, 2023
Characterization of High-Grade Prostate Cancer at Multiparametric MRI: Assessment of PI-RADS Version 2.1 and Version 2 Descriptors Across 21 Readers With Varying Experience (Multi Study) - Beyond the Abstract
May 10, 2023
Page 9 of 57
Start
Prev
4
5
6
7
8
9
10
11
12
13
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free